By Yoon Hang (John) Kim, MD, MPH, ABPM

Board-Certified in Preventive Medicine | Integrative & Functional Medicine | Root Cause Medicine

Osher Fellow, University of Arizona Integrative Medicine Fellowship Graduate | Integrative Functional Medicine Scholarship Recipient

www.yoonhangkim.com| directintegrativecare.com 

You arrive at work feeling fine. By mid-morning, your eyes are burning. Your head pounds. You're congested, exhausted, and struggling to concentrate — but by the time you get home, you feel better. The next day, the cycle repeats. Sound familiar? You may be experiencing Sick Building Syndrome (SBS).

SBS is not a fringe diagnosis or a psychosomatic complaint. It is a well-documented occupational and environmental medicine phenomenon affecting millions of workers worldwide — and understanding its causes, its disproportionate impact on women, and the evidence-based approaches to management can be genuinely life-changing.

What Is Sick Building Syndrome?

Sick Building Syndrome refers to clusters of non-specific symptoms — eye, nose, or throat irritation; headaches; fatigue; difficulty concentrating; skin rashes; and sometimes lower respiratory symptoms — that are worse in a particular building and improve when people leave it.

It is distinct from Building-Related Illness (BRI), which involves specific, diagnosable diseases such as Legionnaires' disease, hypersensitivity pneumonitis, or mold-related asthma, where a single causative agent can be identified. SBS, by contrast, is multifactorial — emerging from the interaction of indoor air chemistry, building design, work organization, psychosocial stress, and individual biology.

Recognizing the Symptoms

SBS typically involves symptom constellations spanning multiple organ systems. Common presentations include:

Eyes

• Burning, itching, watering, redness
• Dry eye — often worsened by low humidity and screen exposure

Upper Airways

• Nasal congestion or rhinorrhea
• Throat irritation, dry cough
• Perception of chemical or musty odors

Lower Airways

• Chest tightness or wheeze (particularly in those with underlying asthma)
• Shortness of breath

Neurologic / General

• Headaches — often frontal or diffuse, pressure-type
• Fatigue disproportionate to activity
• Cognitive difficulty: poor concentration, word-finding difficulties, 'brain fog'
• Dizziness or lightheadedness

Skin

• Dryness, itching, facial or hand rash

A clinically important feature: symptoms are time-linked to a specific building, shared by multiple occupants, and not fully explained by other diagnoses. Physicians should rule out allergic rhinitis, asthma, occupational asthma, hypersensitivity pneumonitis, and infectious causes before attributing symptoms to SBS.

Causes and Mechanisms: A Multifactorial Story

The science is clear that SBS does not have a single cause. Rather, it emerges where marginal air quality, modern synthetic materials, and dampness intersect with stressful, sedentary, screen-heavy work. Evidence points to at least four major contributing domains:

1. Indoor Air Quality and HVAC Failures

Inadequate or poorly maintained ventilation is among the most consistently identified building-level contributors. When HVAC systems fail to deliver adequate fresh outdoor air, indoor pollutants accumulate. Carbon dioxide rises. Volatile organic compounds (VOCs) — emitted by carpets, adhesives, paints, furnishings, cleaning products, and office equipment — concentrate beyond tolerable levels.

VOC exposure contributes to oxidative stress and mucosal irritation, with some compounds documented as sensitizers or low-level toxicants. The problem is compounded in energy-efficient sealed buildings where air exchange rates are deliberately minimized.

2. Biological and Moisture-Related Contaminants

Damp buildings harbor mold, bacterial endotoxins, dust mites, and other bioaerosols. Water intrusion — from roof leaks, condensation, or plumbing failures — creates conditions for microbial growth that can persist invisibly within wall cavities, ceiling tiles, and ductwork.

Mold exposure is particularly relevant from an integrative medicine standpoint. Mycotoxin-producing species such as Stachybotrys chartarum, Aspergillus, and Penicillium have documented immunotoxic, neurologic, and inflammatory effects, particularly in genetically susceptible individuals (HLA-DR/DQ variants associated with impaired biotransformation). This overlaps significantly with the CIRS (Chronic Inflammatory Response Syndrome) framework described by Shoemaker.

3. Physical Environmental Factors

Beyond air quality, the built environment contributes through:

• Temperature extremes or poor thermal regulation
• Low relative humidity (below 30-35%), which desiccates mucous membranes
• Excessive bright, flickering, or glare-producing lighting
• High workstation density in open-plan offices
• Ergonomic deficiencies and prolonged static postures

4. Psychosocial and Organizational Stressors

High job demands, low autonomy, monotonous or repetitive work, poor supervisor relationships, and authoritarian work cultures are consistently and independently associated with higher SBS symptom reporting — even after controlling for physical building factors.

This is not to say that SBS is 'psychological.' Rather, psychosocial stress is a biological phenomenon: it activates the HPA axis, sustains low-grade systemic inflammation, disrupts mucosal immune defenses, and lowers symptom thresholds. The biologic and the psychosocial are not mutually exclusive — they are synergistic.

Why Women Are Disproportionately Affected

Epidemiologic studies consistently find higher SBS symptom prevalence in women than in men. In one large office-worker cohort, 44% of women versus 26% of men met SBS criteria. Across multiple studies, women report more mucosal irritation, headaches, and negative indoor climate ratings than male colleagues in identical buildings.

The reasons are multifactorial and contested, but several lines of evidence are compelling:

Work Roles and Occupational Exposure Patterns

Women remain over-represented in clerical, reception, and service roles that are often located in open-plan, densely occupied spaces with higher exposure to photocopiers, cleaning chemicals, and customer-facing stressors. Even after statistical adjustment, more crowded workstations and higher numbers of people per room cluster in female-dominated roles.

Immunologic and Allergic Vulnerability

Women have higher rates of allergic and autoimmune conditions across virtually every category studied. Female sex is an independent risk factor for allergic sensitization, mast cell reactivity, and reporting of chemical sensitivities — factors that increase SBS susceptibility.

From a functional medicine lens, this intersects with MCAS (Mast Cell Activation Syndrome), which disproportionately affects women and can be exacerbated by VOC, mycotoxin, and endotoxin exposures that are hallmarks of SBS environments.

Hormonal Modulation

Estrogen and progesterone modulate mast cell degranulation, mucosal immune tone, and sensory thresholds. Cyclical hormonal variation may amplify chemical sensitivity and mucosal reactivity in ways that are not present in men, contributing to higher symptom burden.

Psychosocial Compounding and Gender Bias

Women are more frequently positioned in lower-autonomy roles with higher job strain — an independent risk factor for SBS. They also experience disproportionate dismissal of their symptoms: feminist occupational health analyses have documented that gender bias contributed to premature psychologizing of SBS, reducing serious environmental investigation and delaying remediation.

Crucially, large analyses show that even when men and women share similar building conditions and job characteristics, women still report more SBS symptoms — indicating that exposure patterns, job hierarchies, sex-linked immunologic vulnerability, and hormonal biology all contribute, and that this is not a simple reporting artifact.

An Integrative Medicine Approach to Evaluation and Management

Meaningful management of SBS must be environmental and organizational first, and symptom-directed second. Treating only the individual while leaving the building untouched is the equivalent of prescribing antihypertensives without addressing a high-sodium diet — it fails to address root cause.

Building-Level and Organizational Interventions

• Investigate and improve ventilation: verify outdoor air supply rates, maintain HVAC systems, and where feasible, increase fresh air exchange — especially in sealed, energy-efficient buildings.
• Eliminate moisture and mold: repair water intrusion, remediate visible and hidden mold, replace contaminated ceiling tiles and flooring. ERMI (Environmental Relative Moldiness Index) testing can guide assessment.
• Control VOC sources: choose low-emission building materials, paints, and furnishings; store solvents properly; and improve housekeeping practices.
• Redesign workspaces: reduce open-plan overcrowding, improve ergonomics, address lighting (especially flickering fluorescents), and increase access to natural light and outdoor air.
• Address psychosocial factors: involve affected employees in investigation, increase job autonomy where possible, reduce monotonous task loads, and address workload and supervisor relationship issues in parallel with physical remediation.

Individual Medical and Integrative Strategies

For individuals already affected, a multi-domain approach is most consistent with the complexity of the condition:

• Symptomatic pharmacotherapy: nasal corticosteroids and antihistamines for mucosal symptoms; leukotriene modifiers and bronchodilators for reversible lower airway symptoms; lubricating drops for dry eyes; emollients for skin.
• Mast cell stabilization: for individuals with features of MCAS or chemical sensitivity, quercetin, luteolin, and DAO enzyme support may provide adjunctive benefit alongside conventional H1/H2 blockade.
• Antioxidant and mitochondrial support: given evidence for oxidative stress as a mechanistic pathway, N-acetylcysteine (NAC), lipoic acid, CoQ10, and glutathione support (via NAC or IV as appropriate) are reasonable adjuncts — particularly in individuals with high mycotoxin burden.
• Mycotoxin detoxification support: for individuals with documented mold exposure or positive mycotoxin testing, binders such as cholestyramine, activated charcoal, or bentonite clay (per Shoemaker Protocol or modifications) may accelerate mycotoxin clearance.
• Stress physiology and HPA axis support: adaptogenic herbs (Rhodiola rosea, Ashwagandha/KSM-66, Eleuthero), mindfulness-based stress reduction, and vagal tone practices (slow breathing, HRV biofeedback) can help modulate the stress-inflammation-symptom cascade.
• Exposure reduction while remediation is underway: time limits in worst-affected spaces, altered workstation location, use of personal HEPA air purifiers (with the understanding that source control via HVAC is far more effective), regular outdoor breaks, and optimized sleep and recovery.

When Should You Suspect Sick Building Syndrome?

Consider SBS when:

• Multiple occupants of the same building report similar non-specific symptoms
• Symptoms worsen consistently during work hours and improve on weekends, vacations, or remote work periods
• Symptoms are not fully explained by other diagnoses (allergic rhinitis, asthma, infection)
• The building has known issues: dampness, water damage, aging HVAC, recent renovation, or heavy use of synthetic materials
• There is a history of similar complaints among previous occupants
• The patient has features of MCAS, chemical sensitivity, or has tested positive for mycotoxins

In integrative and functional medicine practice, the temporal relationship between building exposure and symptom pattern is the most powerful diagnostic clue. A detailed environmental and occupational history is not optional — it is foundational.

The Bottom Line

Sick Building Syndrome sits at the intersection of environmental medicine, occupational health, immunology, and psychosocial medicine. It is real, measurable, and — critically — largely preventable and treatable when the environmental root causes are taken seriously.

For women especially, who bear a disproportionate symptom burden due to a combination of occupational exposure patterns, sex-linked immunologic vulnerability, and a historical tendency toward symptom dismissal, having a physician who understands both the environmental and biological dimensions of SBS is not a luxury — it is essential.

If you suspect that your symptoms may be building-related, document when and where they occur. Speak with your employer about HVAC maintenance and indoor air quality testing. And consider a consultation with a physician trained in environmental and integrative medicine to evaluate the full picture — because the answer to 'why do I feel sick?' may literally be in the walls around you.

References

1. Seppanen O, Fisk WJ. Summary of human responses to ventilation. Indoor Air. 2004;14(Suppl 7):102-118. PMID: 15330776.

2. Burge PS. Sick building syndrome. Occup Environ Med. 2004;61(2):185-190. PMID: 14739390.

3. Menzies D, Bourbeau J. Building-related illnesses. N Engl J Med. 1997;337(21):1524-1531. PMID: 9366585.

4. Stenberg B, Wall S. Why do women report 'sick building syndrome' more often than men? Soc Sci Med. 1995;40(4):491-502. PMID: 7725123.

5. Brasche S, Bullinger M, Morfeld M, et al. Why do women suffer from sick building syndrome more often than men? — subjective higher sensitivity versus objective causes. Indoor Air. 2001;11(4):217-222. PMID: 11761596.

6. Mendell MJ. Non-specific symptoms in office workers: a review and summary of the epidemiologic literature. Indoor Air. 1993;3(4):227-236.

7. Wyon DP. The effects of indoor air quality on performance and productivity. Indoor Air. 2004;14(Suppl 7):92-101. PMID: 15330775.

8. Shoemaker RC, House D, Ryan JC. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant. Neurotoxicol Teratol. 2014;45:18-26. PMID: 24941140.

9. Shoemaker RC, House D. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial, and mechanisms. Neurotoxicol Teratol. 2006;28(5):573-588. PMID: 16934425.

10. Thrasher JD, Crawley S. The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes. Toxicol Ind Health. 2009;25(9-10):583-615. PMID: 19864272.

11. Redlich CA, Sparer J, Cullen MR. Sick-building syndrome. Lancet. 1997;349(9057):1013-1016. PMID: 9100632.

12. U.S. Environmental Protection Agency. Indoor Air Facts No. 4 (revised): Sick Building Syndrome. EPA Document 402-F-94-004. Available at: www.epa.gov.

Root Cause Medicine  |  directintegrativecare.com  |  Integrative & Functional Medicine